Hospital Universitario Puerta de Hierro Majadahonda · 1×
×1.712k/7kHEMAT
×0.75k/7kGENET
×0.811k/15kONCOL
×0.64k/7kCR
×0.65k/9kPFM
Citations per year
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
'26
Countries citing scholars working at Instituto de Investigación Biomédica de Salamanca
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at Instituto de Investigación Biomédica de Salamanca. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Instituto de Investigación Biomédica de Salamanca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Instituto de Investigación Biomédica de Salamanca more than expected).
Fields of papers published by authors at Instituto de Investigación Biomédica de Salamanca
This network shows the impact of papers affiliated with Instituto de Investigación Biomédica de Salamanca at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Instituto de Investigación Biomédica de Salamanca at the time of their publication.
About Instituto de Investigación Biomédica de Salamanca
In recent decades, authors affiliated with Instituto de Investigación Biomédica de Salamanca have published 4.3k papers, which have received a total of 72.8k indexed citations . Scholars at this organization have produced 663 papers in Hematology, 330 papers in Genetics, 624 papers in Oncology, 308 papers in Pathology and Forensic Medicine and 80 papers in Sensory Systems on the topics of Multiple Myeloma Research and Treatments (427 papers), Chronic Lymphocytic Leukemia Research (198 papers), Protein Degradation and Inhibitors (186 papers), Lymphoma Diagnosis and Treatment (154 papers), Peptidase Inhibition and Analysis (116 papers), Acute Myeloid Leukemia Research (114 papers), Monoclonal and Polyclonal Antibodies Research (101 papers) and CAR-T cell therapy research (88 papers). Their work is cited by papers focused on Hematology (11.8k citations), Genetics (5.1k citations), Oncology (11.4k citations), Cancer Research (4.3k citations) and Pathology and Forensic Medicine (4.9k citations). Authors at Instituto de Investigación Biomédica de Salamanca collaborate with scholars in Spain, United States and United Kingdom and have published in prestigious journals including Blood, International Journal of Molecular Sciences, Journal of Clinical Medicine, Journal of Clinical Oncology and Cancers. Some of Instituto de Investigación Biomédica de Salamanca's most productive authors include María‐Victoria Mateos, Juan P. Bolaños, Jesús F. San Miguel, José J.G. Marı́n, Alberto Órfão, Atanasio Pandiella, Enrique A. Lopez‐Poveda, José M. Lanao, José M. López‐Novoa and Javier De Las Rivas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact